Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-09-04

Clinical Trial Update: An Open Label Study of Oral Minocycline for the Treatment of Patients With Co-occurring Opioid and ATS Dependence [Phase 3]

View source ↗

Summary

An open-label Phase 3 trial is evaluating oral minocycline for individuals with co-occurring opioid (heroin) and amphetamine dependence. The study is sponsored …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Minocycline (minocycline)

Snippet

Sponsor: Universiti Sains Malaysia | Conditions: Heroin Dependence, Amphetamine Dependence | Phase 3 | Status: UNKNOWN